Overview

Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's Disease (AD), which involves the parts of the brain that control memory, thought and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory loss and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk for developing it, improving the accuracy of diagnosis and ability to identify who is at risk, developing, discovering and testing new treatments for behavioural problems in patients with AD. This book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.

Full Product Details

Author:   Eileen M Welsh
Publisher:   Nova Science Publishers Inc
Imprint:   Nova Science Publishers Inc
Weight:   0.820kg
ISBN:  

9781594549397

ISBN 10:   1594549397
Pages:   264
Publication Date:   28 July 2006
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Preface; Insights on Alzheimer's Disease from the Intracerebral Injection and Infusion of Amyloid-ss; The Role of Phospholipase A2 in Alzheimer's Disease; Low Molecular Weight Glycosaminoglycans and Apoptosis: Potential Treatment of Neurodegenerative Disorders Including Alzheimer's Disease; Low Density Lipoprotein Receptor-related Protein 1 (LRP1)- one of the Hallmarks of Alzheimer's Disease and other Complex Degenerative Processes; The Role of Peroxisome Proliferator-Actuvated Receptors in Alheimer's Disease; Role of Sphingomyelin Cycle Signaling System in Alheimer's Disease; Ischemia-reperfusion Factors in Sporadic Alzheimer's Disease; Amyloid Beta (Ass) Peptides in Plasma as Biochemical Markers of Alzheimer's Disease and Mild Cognitive Impairment; Index.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions